TY - JOUR
T1 - Nodal status in major salivary gland cancer
T2 - External validation of a novel N- classification
AU - Lombardi, Davide
AU - Tomasoni, Michele
AU - Missale, Francesco
AU - Smeele, Ludwig E.
AU - Van Lierde, Charlotte
AU - Van Eecke, Matthieu
AU - Pellini, Raul
AU - Mazzola, Francesco
AU - Ravanelli, Marco
AU - Farina, Davide
AU - Clark, Jonathan
AU - Low, Tsui Hui (Hubert)
AU - Gupta, Ruta
AU - Fleming, Jason C.
AU - Ghazal-Asswad, Randa
AU - Locati, Laura
AU - Filauro, Marta
AU - Peretti, Giorgio
AU - Patel, Snehal
AU - Gagliardini, Laura
AU - Bossi, Paolo
AU - Poorten, Vincent Vander
AU - Piazza, Cesare
N1 - Funding Information:
Francesco Missale was supported by EJP-RD fellowship: this project has received funding from the European Union\u2019s Horizon 2000 research and innovation programme under the EJP RD COFUND \u2013 EJP N\u00B0 825575
Publisher Copyright:
© 2025
PY - 2025/8/1
Y1 - 2025/8/1
N2 - Background: Nodal status has been considered an important prognosticator when dealing with MSGC. Since current TNM N-categories do not accurately stratify patients, alternative nodal staging systems have been advocated. Our group has previously proposed 3 novel N-classification models according to number of metastatic nodes, largest diameter of metastatic nodes, and a combination of these two parameters. Aim of the study: Through an external validation in a new multicentric cohort, the present study aims to confirm the superiority of the previously proposed models over the 8th TNM and to assess which of the models is the most reliable. Material and methods: The 3 novel N-classification systems were applied to the validation dataset. Significance of observed differences between primary and validation datasets was assessed using Fisher, chi-squared, and Mann-Whitney tests. Oncological outcomes were overall survival (OS) and recurrence free survival (RFS). Survival estimates were obtained through Kaplan-Meier method. The significance of observed differences in survival and hazard ratios (HRs) according to the levels of each N-classification system was estimated through log-rank test and Cox proportional hazard model, respectively. Results: N-classification considering number of metastatic nodes showed the best prognostic stratification, with significant differences among pN0, pN1 (number of NM < 4), and pN2 (number of NM = 4) for both survival outcomes. This model confirmed to be superior to current TNM N-categories. Conclusions: In patients with MSGC, overall number of involved lymph nodes is the most important prognostic factor, providing a more accurate risk stratification than that obtained using the current TNM classification.
AB - Background: Nodal status has been considered an important prognosticator when dealing with MSGC. Since current TNM N-categories do not accurately stratify patients, alternative nodal staging systems have been advocated. Our group has previously proposed 3 novel N-classification models according to number of metastatic nodes, largest diameter of metastatic nodes, and a combination of these two parameters. Aim of the study: Through an external validation in a new multicentric cohort, the present study aims to confirm the superiority of the previously proposed models over the 8th TNM and to assess which of the models is the most reliable. Material and methods: The 3 novel N-classification systems were applied to the validation dataset. Significance of observed differences between primary and validation datasets was assessed using Fisher, chi-squared, and Mann-Whitney tests. Oncological outcomes were overall survival (OS) and recurrence free survival (RFS). Survival estimates were obtained through Kaplan-Meier method. The significance of observed differences in survival and hazard ratios (HRs) according to the levels of each N-classification system was estimated through log-rank test and Cox proportional hazard model, respectively. Results: N-classification considering number of metastatic nodes showed the best prognostic stratification, with significant differences among pN0, pN1 (number of NM < 4), and pN2 (number of NM = 4) for both survival outcomes. This model confirmed to be superior to current TNM N-categories. Conclusions: In patients with MSGC, overall number of involved lymph nodes is the most important prognostic factor, providing a more accurate risk stratification than that obtained using the current TNM classification.
U2 - 10.1016/j.ejso.2025.110006
DO - 10.1016/j.ejso.2025.110006
M3 - Article
SN - 0748-7983
VL - 51
JO - European Journal of Surgical Oncology
JF - European Journal of Surgical Oncology
IS - 8
M1 - 110006
ER -